Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes

Accumulating evidence supported an association between diabetes and fibroblast growth factor 23 (FGF23). The goal of the present study was to explore alteration in serum FGF23 levels and to assess its value for identifying subclinical atherosclerosis in normoglycemic individuals with a first-degree...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiang, Ma, Xiaojing, Luo, Yuqi, Xu, Yiting, Xiong, Qin, Pan, Xiaoping, Bao, Yuqian, Jia, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048154/
https://www.ncbi.nlm.nih.gov/pubmed/27698482
http://dx.doi.org/10.1038/srep34696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048154/
https://www.ncbi.nlm.nih.gov/pubmed/27698482
http://dx.doi.org/10.1038/srep34696

Ejemplares similares